Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases

Annals of the New York Academy of Sciences

Volumn 893, Issue , 1999, Pages 154-175

  Mattson, Mark P ^a   Pedersen, Ward A ^a   Duan, Wenzhen ^a   Culmsee, Carsten ^a   Camandola, Simonetta ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; AMYLOID PRECURSOR PROTEIN; CALCIUM; CASPASE; DEOXYGLUCOSE; DOPAMINE; GLUCOSE TRANSPORTER; GLUTAMATE TRANSPORTER; HEAT SHOCK PROTEIN; MEMBRANE ENZYME; NEUROTROPHIC FACTOR; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; APOPTOSIS; AUTOPSY; BODY MOVEMENT; BRAIN METABOLISM; CALCIUM HOMEOSTASIS; CONFERENCE PAPER; CORPUS STRIATUM; DIET RESTRICTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOPAMINERGIC NERVE CELL; ENERGY METABOLISM; FOREBRAIN; GENE MUTATION; GLUCOSE METABOLISM; HIPPOCAMPUS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LEARNING; LIPID PEROXIDATION; MEMORY; NERVE CELL DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN DEGRADATION; SUBSTANTIA NIGRA; SYNAPSE;

ANIMALIA;

EID: 0033396991     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07824.x     Document Type: Conference Paper

References (96)

1. 1. Hoyer, S., R. Nitsch & K. Oesterreich. 1991. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J. Neural Transm. 3: 1-14.
2. 2. Jagust, W.J., J.P. Seab, R.H. Huesman, P.E. Valk, C.A. Mathis, B.R. Reed, P.G. Coxson & T.F. Budinger. 1991. Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J. Cereb. Blood Flow Metab. 11: 323-330.
3. 3. Benzi, G. & A. Moretti. 1997. Contributions of mitochondrial alterations to brain aging. In The Aging Brain. M.P. Mattson & J.W. Geddes, Eds. JAI Press. Greenwich, CT. Adv. Cell Aging Gerontol. 2: 129-160.
4. 4. Schapira, A.H., M. Gu, J.W. Taanman, S.J. Tabrizi, T. Seaton, M. Cleeter & J.M. Cooper. 1998. Mitochondria in the etiology and pathogenesis of Parkinson's disease. Ann. Neurol. 44: S89-S98.
5. 5. Butterfield, D.A. & E.R. Stadtman. 1997. Protein oxidation processes in aging brain. In The Aging Brain. M.P. Mattson & J.W. Geddes, Eds. JAI Press. Greenwich, CT. Adv. Cell Aging Gerontol. 2: 161-191.
6. 6. DeKosky, S.T., S.W. Scheff & S.D. Styren. 1996. Structural correlates of cognition in dementia: quantification and assessment of synapse change. Neurodegeneration 5: 417-421.
7. 7. Mattson, M.P. 1997. Cellular actions of β-amyloid precursor protein, and its soluble and fibrillogenic peptide derivatives. Physiol. Rev. 77: 1081-1132.
8. 8. Mattson, M.P., W. Fu, G. Waeg & K. Uchida. 1997. 4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport 8: 2275-2281.
9. 9. Hardy, J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20: 154-159.
10. 10. Mattson, M. P. & Q. Guo. 1998. The Presenilins. Neuroscientist 5: 112-124.
11. 11. Dexter, D.T., C.J. Carter, F.R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner & C.D. Marsden. 1989. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52: 381-389.
12. 12. Jenner, P. & C.W. Olanow. 1998. Understanding cell death in Parkinson's disease. Ann. Neurol. 44: S72-S84.
13. 13. Langston, J.W. 1998. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44: S45-S52.
14. 14. Polymeropoulos, M.H. 1998. Autosomal dominant Parkinson's disease and α-synuclein. Ann. Neurol. 44: S63-S64.
15. 15. Smith, C.D., J.M. Carney, P.E. Starke-Reed, C.N. Oliver, E.R. Stadtman, R.A. Floyd & W.R. Markesbery. 1991. Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88: 10540-10543.
16. 16. Moccoci, P., M.S. MacGarvey & M.F. Beal. 1994. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36: 747-751.
17. 17. Lovell, M.A., W.D. Ehmann, S.M. Butler & W.R. Markesbery. 1995. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45: 1594-1601.
18. 18. Smith, M.A., P.L.R. Harris, L.M. Sayre, J.S. Beckman & G. Perry. 1997. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17: 2653-2657.
19. 19. Good, P.F., P. Werner, A. Hsu, C.W. Olanow & D.P. Perl. 1996. Evidence of neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149: 21-28.
20. 20. Lovell, M.A., W.D. Ehmann, M.P. Mattson & W.R. Markesbery. 1997. Elevated 4-hydroxynonenal levels in ventricular fluid in Alzheimer's disease. Neurobiol. Aging 18: 457-461.
21. 21. Bruce, A.J., S. Bose, W. Fu, C.M. Butt, M.-E. Mirault, N. Taniguchi & M.P. Mattson. 1997. Amyloid β-peptide alters the profile of antioxidant enzymes in hippocampal cultures in a manner similar to that observed in Alzheimer's disease. Pathogenesis 1: 15-30.
22. 22. Gibson, G.E., K.F. Sheu & J.P. Blass. 1998. Abnormalities of mitochondrial enzymes in Alzheimer disease. J. Neural. Transm. 105: 855-870.
23. 23. Sheu, K.F., A.J. Cooper, K. Koike, M. Koike, J.G. Lindsay & J.P. Blass. 1994. Abnormality of the alpha-ketoglutarate dehydrogenase complex in fibroblasts from familial Alzheimer's disease. Ann. Neurol. 35: 312-318.
24. 24. Good, P.F., A. Hsu, P. Werner, D.P. Perl & C.W. Olanow. 1998. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57: 338-342.
25. 25. Alam, Z.I., A. Jenner, S.E. Daniel, A.J. Lees, N. Cairns, C.D. Marsden, P. Jenner & B. Halliwell. 1997. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine in substantia nigra. J. Neurochem. 69: 1196-1203.
26. 26. Alam, Z.I., S.E. Daniel, A.J. Lees, D.C. Marsden, P. Jenner & B. Halliwell. 1997. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J. Neurochem. 69: 1326-1329.
27. 27. Yoritaka, A., N. Hattori, K. Uchida, M. Tanaka, E.R. Stadtman & Y. Mizuno. 1996. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl. Acad. Sci. USA 93: 2696-2701.
28. 28. Mytilineou, C., P. Werner, S. Molinari, A. Di Rocco, G. Cohen & M. D. Yahr. 1994. Impaired oxidative decarboxylation of pyruvate in fibroblasts from patients with Parkinson's disease. J. Neural. Transm. Park. Dis. Dement. Sect. 8: 223-228.
29. 29. Sheehan, J.P., R.H. Swerdlow, W.D. Parker, S.W. Miller, R.E. Davis & J.B. Tuttle. 1997. Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease. J. Neurochem. 68: 1221-1233.
30. 30. Gabuzda, D., J. Busciglio, L. Chen, P. Matsudaira & B. Yankner. 1994. Inhibition of energy metabolism alters the processing of amyloid precursor protein and induces a potentially amyloidogenic derivative. J. Biol. Chem. 269: 13623-13628.
31. 31. Goodman, Y. & M.P. Mattson. 1994. Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury. Exp. Neurol. 128: 1-12.
32. 2+ homeostasis and cell death. J. Neurosci. 15: 6239-6249.
33. 33. Mattson, M.P., B. Cheng, D. Davis, K. Bryant, I. Lieberburg & R.E. Rydel. 1992. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12: 376-389.
34. 34. Kruman, I., A.J. Bruce-Keller, D.E. Bredesen, G. Waeg & M.P. Mattson. 1997. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17: 5089-5100.
35. 35. Mark, R.J., M.A. Lovell, W.R. Markesbery, K. Uchida & M.P. Mattson. 1997. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68: 255-264.
36. 36. Mark, R.J., Z. Pang, J.W. Geddes, K. Uchida & M.P. Mattson. 1997. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17: 1046-1054.
37. 37. Keller, J.N., Z. Pang, J.W. Geddes, J.G. Begley, A. Germeyer, G. Waeg & M.P. Mattson. 1997. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid-β peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69: 273-284.
38. 38. Blanc, E.M., J.N. Keller, S. Fernandez, & M.P. Mattson. 1998. 4-hydroxynonenal, a lipid peroxidation product, inhibits glutamate transport in astrocytes. Glia 22: 149-160.
39. 39. Goodman, Y., A.J. Bruce, B. Cheng & M.P. Mattson. 1996. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66: 1836-1844.
40. +-ATPase activity, glucose transport and glutamate transport induced by amyloid β-peptide and iron. J. Neurosci. Res. 50: 522-530.
41. 41. Blanc, E.M., M. Toborek, R.J. Mark, B. Hennig & M.P. Mattson. 1997. Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem. 68: 1870-1881.
42. 42. Keller, J.N., M.S. Kindy, F.W. Holtsberg, D.K. St Clair, H.-C. Yen, A. Germeyer, S.M. Steiner, A.J. Bruce-Keller, J.B. Hutchins & M.P. Mattson. 1998. Mitochondrial MnSOD prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. J. Neurosci. 18: 687-697.
43. 43. Kruman, I., Z. Pang, J.W. Geddes & M.P. Mattson. 1999. Pivotal role of mitochondrial calcium uptake in neural cell apoptosis and necrosis. J. Neurochem. 72: 529-540.
44. 44. Bozner, P., V. Grishko, S.P. LeDoux, G.L. Wilson, Y.C. Chyan & M.A. Pappolla. 1997. The amyloid beta protein induces oxidative damage of mitochondrial DNA. J. Neuropathol. Exp. Neurol. 56: 1356-1362.
45. 45. Furukawa, K., B. Sopher, R.E. Rydel, J.G. Begley, G.M. Martin & M.P. Mattson. 1996. Increased activity-regulating and neuroprotective efficacy of α-secretase-derived secreted APP is conferred by a C-terminal heparin-binding domain. J. Neurochem. 67: 1882-1896.
46. 46. Lannfelt, L., H. Basun, L.O. Wahlund, B.A. Rowe & S.L. Wagner. 1995. Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nature Med. 1: 829-832.
47. 47. Mattson, M.P., B. Cheng, A. Culwell, F. Esch, I. Lieberburg & R.E. Rydel. 1993. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of β-amyloid precursor protein. Neuron 10: 243-254.
48. 48. Smith-Swintosky, V.L., L.C. Pettigrew, S.D. Craddock, A.R. Culwell, R.E. Rydel & M.P. Mattson. 1994. Secreted forms of β-amyloid precursor protein protect against ischemic brain injury. J. Neurochem. 63: 781-784.
49. + channels and suppression of neuronal activity by secreted β-amyloid precursor protein. Nature 379: 74-78.
50. 50. Barger, S.W. & M.P. Mattson. 1996. Induction of neuroprotective κB-dependent transcription by secreted forms of the Alzheimer's β-amyloid precursor. Mol. Brain Res. 40: 116-126.
51. 2+ accumulation. Proc. Natl. Acad. Sci. USA 92: 9328-9332.
52. 52. Mattson, M.P., Y. Goodman, H. Luo, W. Fu & K. Furukawa. 1997. Activation of NF-κB protects hippocampal neurons against oxidative stress-induced apoptosis: evidence for induction of Mn-SOD and suppression of peroxynitrite production and protein tyrosine nitration. J. Neurosci. Res. 49: 681-697.
53. 53. Mattson, M. P., Z. H. Guo & J. D. Geiger. 1999. Secreted form of amyloid precursor protein attenuates oxidative impairment of glucose and glutamate transport in synaptosomes by a cyclic GMP-mediated mechanism. J. Neurochem. 73: 532-537.
54. 54. Guo, Q., B.L. Sopher, D.G. Pham, K. Furukawa, N. Robinson, G.M. Martin & M.P. Mattson. 1997. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17: 4212-4222.
55. 55. Guo, Q., S. Christakos, N. Robinson & M.P. Mattson. 1998. Calbindin blocks the pro-apoptotic actions of mutant presenilin-1: reduced oxidative stress and preserved mitochondrial function. Proc. Natl. Acad. Sci. USA 95: 3227-3232.
56. 56. Guo, Q., W. Fu, B.L. Sopher, M.W. Miller, C.B Ware, G.M. Martin & M.P. Mattson. 1999. Increased vulnerability of hippocampal neurons to excitotoxic necrosis in presenilin-1 mutant knockin mice. Nature Med. 5: 101-107.
57. 57. Begley, J.G., W. Duan, K. Duff & M.P. Mattson. 1999. Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice. J. Neurochem. 72: 1030-1039.
58. 58. Guo, Q., K. Furukawa, B.L. Sopher, D.G. Pham, N. Robinson, G.M. Martin & M.P. Mattson. 1996. Alzheimer's PS-1 mutation perturbs calcium homeostasis and sensitizes PC12 cells to death induced by amyloid β-peptide. NeuroReport 8: 379-383.
59. 59. Mattson, M.P., N. Robinson & Q. Guo. 1997. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. NeuroReport 8: 3817-3821.
60. 60. Guo, Q., W. Fu, B.L. Sopher, F.W. Holtsberg, S.M. Steiner & M.P. Mattson. 1999. Superoxide mediates the apoptosis-enhancing action of presenilin-1 mutations. J. Neurosci. Res. 56: 457-470.
61. 61. Duan, W., D.M. Gash, V. Rangnekar & M.P. Mattson. 1999. Participation of Par-4 in degeneration of dopaminergic neurons in primate and rodent models of Parkinson's disease. Ann. Neurol. 46: 587-597.
62. 62. Tipton, K.F. & T.P. Singer. 1993. Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J. Neurochem. 61: 1191-1206.
63. 63. El-Agnaf, O.M., R. Jakes, M.D. Curran, D. Middleton, R. Ingenito, E. Bianchi, A. Pessi, D. Neill, & A. Wallace. 1998. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett. 440: 71-75.
64. 64. Mattson, M.P. 1998. Modification of ion homeostasis by lipid peroxidation: roles in neuronal degeneration and adaptive plasticity. Trends Neurosci. 21: 53-57.
65. 65. Anglade, P., A. Mouatt-Prigent, Y. Agid & E. Hirsch. 1996. Synaptic plasticity in the caudate nucleus of patients with Parkinson's disease. Neurodegeneration 5: 121-128.
66. 66. Mitchell, I.J. & C. B. Carroll. 1997. Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action. Neurosci. Biobehav. Rev. 21: 469-475.
67. 67. Mattson, M.P., J.N. Keller & J.G. Begley. 1998. Evidence for synaptic apoptosis. Exp. Neurol. 153: 35-48.
68. 68. Mattson, M.P., J. Partin & J.G. Begley. 1998. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites. Brain Res. 807: 167-176.
69. 69. Duan, W., V. Rangnekar & M.P. Mattson. 1999. Par-4 production in synaptic compartments following apoptotic and excitotoxic insults: evidence for a pivotal role in mitochondrial dysfunction and neuronal degeneration. J. Neurochem. 72: 2312-2322.
70. 70. Sells, S.F., S.-S. Han, S. Muthukkumar, N. Maddiwar, R. Johnstone, E. Boghaert, D. Gillis, G. Liu, P. Nair, S. Monnig, P. Collini, M.P. Mattson, V. P. Sukhatme, S.G. Zimmer, D.P. Wood, J.W. McRoberts, Y. Shi & V.M. Rangnekar. 1997. Expression and function of the leucine zipper protein Par-4 in apoptosis. Mol. Cell. Biol. 17: 3823-3832.
71. 71. Guo, Q., W. Fu, J. Xie, H. Luo, S.F. Sells, J.W. Geddes, V. Bondada, V.M. Rangnekar & M.P. Mattson. 1998. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer's disease. Nature Med. 4: 957-962.
72. 72. Diaz-Meco, M.T., M.M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz & J. Moscat. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86: 777-786.
73. 14C]-2-deoxyglucose uptake in the MPTP-treated marmoset: relationship to locomotor activity. J. Neural. Transm. Gen. Sect. 101: 65-82.
74. 74. Sorbi, S., S. Piacentini, S. Latorraca, P. Piersanti & L. Amaducci. 1995. Alterations in metabolic properties in fibroblasts in Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9: 73-77.
75. 75. Messier, C. & M. Gagnon. 1996. Glucose regulation and cognitive functions: relation to Alzheimer's disease and diabetes. Behav. Brain Res. 75: 1-11.
76. 76. Vanhanen, M. & H. Soininen. 1998. Glucose intolerance, cognitive impairment and Alzheimer's disease. Curr. Opin. Neurol. 11: 673-677.
77. 77. Molchan, S.E., J.L. Hill, A.M. Mellow, B.A. Lawlor, R. Martinez & T. Sunderland. 1990. The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines. Int. Psychogeriatr. 2: 99-122.
78. 78. Pedersen, W.A., C. Culmsee, D. Ziegler, J.P. Herman & M.P. Mattson. 1990. Aberrant stress response associated with severe hypoglycemia in a transgenic mouse model of Alzheimer's disease. J. Mol. Neurosci. 13: 159-165.
79. 79. Sandyk, R. 1993. The relationship between diabetes mellitus and Parkinson's disease. Int. J. Neurosci. 69: 125-130.
80. 80. Shimizu, H., Y, Shimomura, M. Takahashi, I. Kobayashi & S. Kobayashi. 1990. Dopamine receptor in the streptozotocin-induced diabetic rats. Exp. Clin. Endocrinol. 95: 263-266.
81. 81. Sohal, R.S. & R. Weindruch. 1996. Oxidative stress, caloric restriction, and aging. Science 273: 59-63.
82. 82. Cefalu, W.T., J.D. Wagner, Z.Q. Wang, A.D. Bell-Farrow, J. Collins, D. Haskell, R. Bechtold & T. Morgan. 1997. A study of caloric restriction and cardiovascular aging in cynomolgus monkeys (Macaca fascicularis): a potential model for aging research. J. Gerontol. A Biol. Sci. Med. Sci. 52: B10-B19.
83. 83. Lane, M.A., D.J. Baer, W.V. Rumpler, R. Weindruch, D.K. Ingram, E.M. Tilmont, R.G. Cutler & G.S. Roth. 1996. Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents. Proc. Natl. Acad. Sci. USA 93: 4159-4164.
84. 84. Dubey, A., M.J. Forster, H. Lal & R.S. Sohal. 1996. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of mouse. Arch. Biochem. Biophys. 333: 189-197.
85. 85. Aksenova, M.V., M.Y. Aksenov, J.M. Carney & D.A. Butterfield. 1998. Protein oxidation and enzyme activity decline in old brown Norway rats are reduced by dietary restriction. Mech. Ageing Dev. 100: 157-168.
86. 86. Grant, W. 1997. Dietary links to Alzheimer's disease. Alz. Dis. Rev. 2: 42-55.
87. 87. Bruce-Keller, A.J., G. Umberger, R. McFall & M.P. Mattson. 1999. Food restriction reduces brain damage and improves behavioral outcome following excitotoxic and metabolic insults. Ann. Neurol. 45: 8-15.
88. 88. Duan, W. & M.P. Mattson. 1999. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurochem. Submitted.
89. 89. Lee, J., A.J. Bruce-Keller, U. Kruman, S.L. Chan & M.P. Mattson. 1999. 2-deoxy-D-glucose protects hippocampal neurons against excitotoxic and oxidative injury: involvement of stress proteins. J. Neurosci. Res. In press.
90. 90. Yu, Z.F. & M.P. Mattson. 1999. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J. Neurosci. Res. 57: 830-839.
91. 2+ influx in cultured hippocampal neurons. Neuron 4: 105-117.
92. 92. Cheng, B. & M.P. Mattson. 1992. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp. Neurol. 117: 114-123.
93. 93. Busciglio, J., A. Lorenzo, J. Yeh & B.A. Yankner. 1995. β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14: 879-888.
94. 94. Elliott, E., M.P. Mattson, P. Vanderklish, G. Lynch, I. Chang & R.M. Sapolsky. 1993. Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61: 57-67.
95. 95. Stein-Behrens, B., M.P. Mattson, I. Chang, M. Yeh & R.M. Sapolsky. 1994. Stress excacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 1: 5373-5380.
96. 96. Hsiao, K., P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang & G. Cole. 1996. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274: 99-102.